Literature DB >> 19913490

The wheat germ cell-free protein synthesis system: a key tool for novel malaria vaccine candidate discovery.

Takafumi Tsuboi1, Satoru Takeo, Thangavelu U Arumugam, Hitoshi Otsuki, Motomi Torii.   

Abstract

Malaria kills more than a million people a year, causes malady in about three hundred million people and poses risk to approximately 40% of the world's population living in malarious countries. This disease is re-emerging mainly due to the development of drug-resistant parasites and insecticide-resistant mosquitoes. Therefore, we are now forced to resort to remedy through vaccination. Until now, not even a single licensed malaria vaccine has been developed despite intensive efforts. Even the efficacy of RTS,S, the most advanced and promising vaccine candidate in the pipeline of malaria vaccine development, was only around 50% based on a number of clinical trials. These facts urge malaria researchers to urgently enrich this pipeline, as much as possible, with potential vaccine candidates. With the availability of malaria genome database, the enrichment of this pipeline is possible if we could now employ an efficient protein expression technology to decode the malaria genomic data, without any codon optimization, into quality recombinant proteins. Then, these synthesized recombinant proteins can be characterized and screened for discovering novel potential vaccine targets. The wheat germ cell-free protein synthesis system will be a promising tool to this end. This review highlights the recent successes in synthesizing quality malaria proteins using this tool. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913490     DOI: 10.1016/j.actatropica.2009.10.024

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  27 in total

Review 1.  Cell-free protein synthesis: applications come of age.

Authors:  Erik D Carlson; Rui Gan; C Eric Hodgman; Michael C Jewett
Journal:  Biotechnol Adv       Date:  2011-10-08       Impact factor: 14.227

Review 2.  Plasmodium immunomics.

Authors:  Denise L Doolan
Journal:  Int J Parasitol       Date:  2010-09-16       Impact factor: 3.981

3.  N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity.

Authors:  Mayumi Tachibana; Yimin Wu; Hideyuki Iriko; Olga Muratova; Nicholas J MacDonald; Jetsumon Sattabongkot; Satoru Takeo; Hitoshi Otsuki; Motomi Torii; Takafumi Tsuboi
Journal:  Clin Vaccine Immunol       Date:  2011-06-29

4.  In vitro human cell-free expression system for synthesis of malaria proteins.

Authors:  R Yadavalli; C Ledger; T Y Sam-Yellowe
Journal:  Parasitol Res       Date:  2012-07-11       Impact factor: 2.289

5.  Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen.

Authors:  Thangavelu U Arumugam; Satoru Takeo; Tsutomu Yamasaki; Amporn Thonkukiatkul; Kazutoyo Miura; Hitoshi Otsuki; Hong Zhou; Carole A Long; Jetsumon Sattabongkot; Jennifer Thompson; Danny W Wilson; James G Beeson; Julie Healer; Brendan S Crabb; Alan F Cowman; Motomi Torii; Takafumi Tsuboi
Journal:  Infect Immun       Date:  2011-09-06       Impact factor: 3.441

6.  Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.

Authors:  Kazutoyo Miura; Eizo Takashima; Bingbing Deng; Gregory Tullo; Ababacar Diouf; Samuel E Moretz; Daria Nikolaeva; Mahamadou Diakite; Rick M Fairhurst; Michael P Fay; Carole A Long; Takafumi Tsuboi
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

7.  Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development.

Authors:  Jack S Richards; Thangavelu U Arumugam; Linda Reiling; Julie Healer; Anthony N Hodder; Freya J I Fowkes; Nadia Cross; Christine Langer; Satoru Takeo; Alex D Uboldi; Jennifer K Thompson; Paul R Gilson; Ross L Coppel; Peter M Siba; Christopher L King; Motomi Torii; Chetan E Chitnis; David L Narum; Ivo Mueller; Brendan S Crabb; Alan F Cowman; Takafumi Tsuboi; James G Beeson
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

8.  Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates.

Authors:  Keith Limbach; Joao Aguiar; Kalpana Gowda; Noelle Patterson; Esteban Abot; Martha Sedegah; John Sacci; Thomas Richie
Journal:  Malar J       Date:  2011-03-16       Impact factor: 2.979

9.  Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine.

Authors:  Maryam Amidi; Markus de Raad; Daan J A Crommelin; Wim E Hennink; Enrico Mastrobattista
Journal:  Syst Synth Biol       Date:  2010-10-26

10.  Developmental transcriptomic features of the carcinogenic liver fluke, Clonorchis sinensis.

Authors:  Won Gi Yoo; Dae-Won Kim; Jung-Won Ju; Pyo Yun Cho; Tae Im Kim; Shin-Hyeong Cho; Sang-Haeng Choi; Hong-Seog Park; Tong-Soo Kim; Sung-Jong Hong
Journal:  PLoS Negl Trop Dis       Date:  2011-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.